Red Flags to Look Out for When Purchasing Exosomes

Buying an exosome or extracellular-vesicle product can be difficult because not every seller provides the same level of transparency.

A professional website, impressive particle count, or scientific-sounding product description doesn't necessarily tell you who manufactured the product, what's actually in the vial, or how it was tested.

Before purchasing, watch for these red flags.

Red Flag #1: No Batch-Specific Certificate of Analysis

One of the biggest warning signs is a seller that cannot provide meaningful documentation for the product being sold.

Ask for a batch-specific Certificate of Analysis (COA).

Ideally, you should be able to follow:

Vial → Lot number → COA → Test results

A generic specification sheet—or a COA from an unrelated batch—isn't the same thing as documentation tied to the lot you're purchasing.

And don't stop at simply seeing a COA. Check what was actually tested.

See How to Read an Exosome Certificate of Analysis.

Red Flag #2: You Can't Figure Out Who Actually Makes It

The company selling an exosome product may be a distributor rather than the manufacturer. That's perfectly normal.

The red flag is when nobody will clearly tell you who the manufacturer is.

Be cautious when a company talks extensively about “our lab,” “our scientists,” or “our manufacturing” but provides little verifiable information about the actual facility producing the product.

Ask:

Who manufactures this? Where is it manufactured?

If those simple questions produce vague answers, keep asking.

Red Flag #3: The Biological Source and Cell Passage History Are Vague

Extracellular vesicles originate from cells.

You should therefore be able to determine what biological source is being represented and, when cultured cells are used, how those cells are managed during manufacturing.

One important question is cell passage history.

A passage occurs when cultured cells are transferred and expanded again. As cells undergo repeated rounds of expansion, they can develop changes associated with replicative aging and cellular senescence. Research has shown that these changes can also affect the composition and characteristics of the extracellular vesicles the cells release.

That makes passage history more than an obscure laboratory detail. It can be a meaningful consideration when evaluating how an EV product is manufactured.

Ask questions such as:

• What type of cells are used?
• What is the original biological source?
• How are the cells expanded?
• Is passage number monitored and controlled?
• Can the manufacturer provide information about its cell-culture controls?

This does not mean there is one universal passage number at which every cell culture suddenly becomes unsuitable. Cell type, culture conditions, manufacturing methods and other factors matter.

But a manufacturer should understand and control its cell-expansion process. If a seller cannot provide meaningful information about the source cells or how they are expanded and controlled, that deserves additional scrutiny.

We'll explore this in greater detail in What Does Cell Passage Number Mean in Exosome Manufacturing?

Red Flag #4: Huge Particle Numbers With Little Explanation

100 billion!

200 billion!

500 billion!

Those numbers make great marketing.

But ask:

500 billion what—and measured how?

Particle-counting methods detect particles according to the characteristics and limitations of the analytical method. A particle count alone does not establish that every counted particle is an exosome.

Look for supporting information such as:

• analytical method
• particle-size distribution
• EV-associated markers
• protein measurements
• other characterization

A bigger number by itself doesn't automatically mean a better product.

See How Are Extracellular Vesicle Particle Counts Measured?

Red Flag #5: “Lab Tested” With No Actual Test Results

“Lab tested” sounds impressive.

It also tells you almost nothing by itself.

What was tested?

Look for actual reported results rather than a badge or marketing statement.

Depending on the product documentation, that may include things such as:

particle characterization, EV-associated markers, protein measurements, sterility, endotoxin, cell count, osmolality or particulate matter.

Different tests answer different questions.

The more specific the claim, the easier it should be to determine what evidence supports it.

Red Flag #6: No Lot Number or Traceability

A product should not feel like a mystery vial.

If documentation is presented, you should be able to determine whether it actually corresponds to the product you're considering.

Look for:

Product → Lot → Documentation

Without lot traceability, even an impressive-looking COA becomes much less useful.

Red Flag #7: Nobody Can Explain Storage or Shipping

Ask what happens between manufacturing and delivery.

• Where is the product stored?
• At what temperature?
• Who ships it?
• Is temperature-controlled shipping required?

For products requiring cold-chain handling, vague answers deserve additional scrutiny.

A product's history doesn't stop when manufacturing ends.

Learn more in What Is Cold-Chain Storage and Why Does It Matter?.

Red Flag #8: Packaging Claims That Nobody Can Explain

Packaging deserves attention—but avoid simplistic rules.

For example, seeing a glass vial versus a polymer container does not by itself prove one product is superior.

Instead ask:

What container is used? Why was it selected? Is it appropriate for the formulation and storage conditions?

Be skeptical of sellers who use packaging itself as proof of product quality without supporting information.

This is an area where documentation matters more than appearances.

Red Flag #9: “FDA Registered” Is Presented Like “FDA Approved”

These terms are not interchangeable.

FDA registration of an establishment does not mean FDA has approved the product being sold.

FDA currently states that there are no FDA-approved exosome products.

Therefore, language designed to make “FDA registered” look like “FDA-approved exosomes” should immediately prompt more questions.

Red Flag #10: Extraordinary Medical Promises

Be especially cautious when marketing promises that an exosome product will:

reverse aging, regenerate joints, cure disease, repair organs, restore neurological function, or guarantee particular medical outcomes.

Scientific terminology does not turn a marketing promise into clinical evidence.

FDA has specifically warned consumers about unapproved regenerative-medicine products, including products marketed as containing exosomes.

The bigger the medical promise, the more evidence you should demand.

What Transparency Looks Like

A trustworthy seller shouldn't make basic product information unnecessarily difficult to obtain.

Before buying, you should be able to ask:

• Who manufactured it?
• What is the biological source?
• What lot am I purchasing?
• Can I see that lot's COA?
• How was particle quantity measured?
• What additional characterization was performed?
• What finished-product testing is documented?
• How is the product stored and shipped?
• Can the seller substantiate its manufacturing and regulatory claims?

At Express Biologics, we distribute HydroKarma products manufactured by KWEHEALTH and make batch-specific documentation and educational material available so buyers can examine what the reported testing actually means.

The goal isn't to tell you:

“Trust us.”

It's to give you enough information to verify what you can for yourself.

The Bottom Line

The biggest red flag isn't necessarily one particular number, container or marketing phrase.

It's a lack of transparency.

If you can't determine who made the product, where it came from, which lot you're buying, what testing was performed, or how it was handled, don't let an impressive website or enormous particle count answer those questions for you.